UNSPSC 51373307: Acetaminophen/butalbital/codeine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373307 Acetaminophen/butalbital/codeine is a Commodity code with minimal recent state and local procurement activity aligned to its nominal pharmaceutical scope. The single recent opportunity posted under this code is a Seminole County, Florida IFB for Naloxone and Safe Drug Deactivation Systems — a category mismatch that suggests the code does not currently capture meaningful volume in state and local opioid-response procurement or pharmaceutical acquisition broadly. The opportunity itself (IFB 60459723LAS, due July 26, 2023) targets emergency-response and harm-reduction supplies rather than the acetaminophen/butalbital/codeine formulation the code nominally describes, indicating either a cataloging error in the county's sourcing or a deliberate use of an unrelated code to classify a different product family.

Seminole County is the sole issuing body with recent documented activity. The procurement calls for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford; vendors must include shipping and delivery costs in their proposals and comply with drug-free workplace, E-Verify, and insurance-coverage requirements. The two-year initial term with one-year renewal option and potential FEMA funding signal ongoing operational demand. Absent other recent opportunities under this code in other states or jurisdictions, pursuit should focus on clarifying whether Seminole County and similar Florida health departments are sourcing comparable naloxone or deactivation-system contracts under alternative UNSPSC codes, as the current code shows little practical relevance to state and local pharmaceutical or emergency-response procurement today.